Altimmune (ALT) stock dips as higher-than-expected R&D costs lead to a Q4 2025 earnings miss for the company. Read more here.

LFT slightly high. There is no pain. No yellowing of the eyes. No weakness. So it is easy to brush it aside. But the liver rarely shouts in the beginning. It whispers.Liver Function Tests, or LFTs, ...

Successfully started 216 patients on IBTROZI® (taletrectinib) in the fourth quarter of 2025, for a total of 432 new patient starts since launch in the second half of ...

Q4 2025 net product revenues of $54.3 million; 2025 full-year net product revenues of $227.3 million, representing a 49% increase over 2024 full-year net product revenues ...

Add Yahoo as a preferred source to see more of our stories on Google. Gold medalist Alysa Liu celebrates on the podium at the 2026 Milano Cortina Olympics. (Jamie Squire/Getty Images) Alysa Liu is one ...

AST SpaceMobile shares are dropping after the company said it would take on $1 billion worth of debt as it looks to develop a space-based cellular network. On Thursday, the satellite maker announced ...

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. AST SpaceMobile (NasdaqGS:ASTS) has successfully deployed its BlueBird 6 satellite, creating ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

MIDLAND, Texas--(BUSINESS WIRE)--AST SpaceMobile, Inc. (“AST SpaceMobile”) (NASDAQ: ASTS), the company building the first and only space-based cellular broadband network accessible directly by ...

AST SpaceMobile has successfully unfolded its massive 2,400 square-foot satellite in orbit as the company tries to challenge SpaceX’s cellular Starlink service. On Tuesday, AST SpaceMobile posted a ...